PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20587667-7	2010	In total, these results suggest that clinical trials of selumetinib in breast cancer and NSCLC might select patients whose tumors harbor raf and ras mutations, respectively.	AZD 6244	56-67	zinc fingers and homeoboxes 2	Homo sapiens	137-140